BridgeMD
New treatment option for Cancer
Official title Characterisation of the Immune Infiltrate and Molecular Features of Thymic Epithelial Tumors Tumors (TETs)
ClinicalTrials.gov ID: NCT05558644
What this study is testing
- What it's testing
- The IMMUNO-TET trial aims to assess the feasibility of characterising the immune environment of TETs and the constitutional and somatic molecular profiles of patients with localised thymic epithelial tumour (TET).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient with suspicion of localised thymic epithelial tumour.
- Age ≥ 18 years.
- Treatment-naïve patient for this disease.
- Patient with an indication for thymectomy and thymomectomy in one of the partner centers.
- Signed informed consent form of the patient.
You likely can't join if
- Neoadjuvant chemotherapy.
- No social security affiliation.
- Person under legal protection.
- Other neoplasia in progress or cured within the last 3 years (except for operated carcinoma in situ).
The study team makes the final eligibility decision.
Where it's taking place
- Paris, France
- Suresnes, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, France; Suresnes, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.